Vascularizing neurospheroids to probe vascular contributions to α-synuclein pathology in Parkinson's disease
Anika Alim, Sandra Lwin, Purnopama Saha, Yoongyeong Baek, Myungwoon LeeiD, Jungwook PaekiD
Abstract
Neurodegenerative diseases are increasingly associated with vascular dysfunction beyond progressive neuronal degeneration, yet how vascular pathology contributes to disease progression remains poorly understood, largely due to the lack of a neurodegenerative disease model capable of capturing neuronal pathology alongside associated vascular dysfunction. Here, we developed a microengineered 3D vascularized brain tissue model that integrates neurospheroids with a self-assembled, perfusable vascular network to recapitulate key features of the neurovascular interface. Using this model, we investigated the vascular contribution to Parkinson's disease pathology by introducing -synuclein preformed fibrils into the engineered vasculature. Intravascular -syn fibril exposure induced endothelial barrier disruption, vascular leakage, inflammation, and vascular regression. Notably, this vascular insult was accompanied by intraneuronal -synuclein aggregation within neurospheroids, suggesting that vascular dysfunction may facilitate the exposure of neural tissue to pathogenic -synuclein. Our neurodegenerative disease modeling approach establishes a versatile and tractable platform for investigating vascular contributions to neurodegenerative disease progression.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Microphysiological engineering of the capillary interface of substantia nigra dopaminergic neurons to study vascular alterations in Parkinson's Disease
Anika Alim, Yoongyeong Baek, … Jungwook Paek·bioRxiv·May 14, 2025
- Modeling Alpha-Synuclein Pathology in a Human Brain-Chip to Assess Blood-Brain Barrier Disruption in Parkinson's Disease
I. Pediaditakis, K. R. Kodella, … K. Karalis·bioRxiv·Jul 22, 2020
- The impact of alpha-synuclein aggregates on blood-brain barrier integrity in the presence of neurovascular unit cells
Hamdam Hourfar, Farhang Aliakbari, … Dina Morshedi·International Journal of Biological MacromoleculesPeer-reviewed·Dec 17, 2022
- Human pericytes degrade alpha-synuclein aggregates in a strain-dependent manner
Birger Victor Dieriks, Blake Highet, … Mike Dragunow·bioRxiv·Jun 8, 2022
- Intranigral injection of Alpha-Synuclein pre-formed fibrils leads to BBB compromise and Bilateral Dopaminergic Neurodegeneration in A53T Alpha-Synuclein transgenic mice.
Soumitra Ghosh, Han Lin, … William J. Meilandt·Discover NeurosciencePeer-reviewed·Aug 27, 2026
- Vascularized midbrain assembloids show neuroinflammation and dopaminergic neuron vulnerability in Parkinsons Disease
Anna-Sophie Zimmermann, Sònia Sabaté‐Soler, … Jens Christian Schwamborn·bioRxiv·Aug 6, 2025